Clinical Trials Browser

Phase 1/2 × BID protein, human × Clear all

NCT04820023 2025-06-06

Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment

Phase 1/2 Terminated

45 enrolled 19 charts

NSCLC

NCT01254136 2012-01-25

Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer

Phase 1/2 Terminated

Breast Neoplasms